Volta Medical’s AI based solution for patients in atrial fibrillation achieves robust validation in first peer-reviewed publication
August 31, 2022 08:00 ET
|
Volta Medical
Volta VX1 decision support software reproduces expert-physician electrogram (EGM) analysis that can assist physicians in the real-time identification of specific abnormal electrograms in a persistent...
Volta Medical VX1 AI Software to be Featured at Heart Rhythm 2022
April 27, 2022 08:00 ET
|
Volta Medical
- Company’s VX1 AI software for use in atrial fibrillation will be featured during several events at the Congress - MARSEILLE, France and PROVIDENCE, R.I., April 27, 2022 (GLOBE NEWSWIRE) -- Volta...
First U.S. patients with persistent cardiac arrythmias treated using Volta Medical’s artificial intelligence-based analysis
December 21, 2021 08:00 ET
|
Volta Medical
Novel, FDA-cleared and CE-certified medical device is designed to help cardiologists identify cardiac abnormalities in patients undergoing ablation treatment for persistent, drug-resistant atrial...